The Role of GH and IGF-I in Mediating Anabolic Effects of Testosterone on Androgen-Responsive MuscleCarlo Serra, Carl Morris|Endocrinology|2010Cited by 91
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M. Birch, Joe N. Kornegay, Brittany A. Fickau et al.|Science Translational Medicine|2023Cited by 68
SGT-001 Micro-dystrophin gene therapy for Duchenne muscular dystrophyJoel Schneider, Carl Morris, Jorge González et al.|Neuromuscular Disorders|2017Cited by 20
Quantification of microdystrophin and correlation to circulating biomarkersKristy J. Brown, Carl Morris, Michael W. Lawlor et al.|Neuromuscular Disorders|2017Cited by 1
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophyMichael J. Struharik, Xiaoqing Pan, Amanda K. Bettis et al.|UNC Libraries|2024Cited by 0